Arrowhead Pharmaceuticals Overview
- Founded
- 1989
- Status
- Public
- Employees
- 232
- Stock Symbol
- ARWR
- Investments
- 9
- Share Price
- $85.98
- (As of Thursday Closing)
Arrowhead Pharmaceuticals General Information
Description
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.
Contact Information
Website
www.arrowheadpharma.com
Formerly Known As
InterActive Group, Arrowhead Research
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Stock Exchange
NAS
Primary Office
- 177 East Colorado Boulevard
- Suite 700
- Pasadena, CA 91105
- United States
+1 (626) 000-0000
Arrowhead Pharmaceuticals Timeline
Arrowhead Pharmaceuticals Stock Performance
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $85.98 | $85.84 | $32.86 - $92.60 | $8.95B | 104M | 733K | -$1.07 |
Arrowhead Pharmaceuticals Financials Summary
|
In Thousands, USD |
TTM 31-Mar-2021 | FY 2020 30-Sep-2020 | FY 2019 30-Sep-2019 | FY 2018 30-Sep-2018 |
|---|---|---|---|---|
| EV | 6,598,016 | 4,138,470 | 2,448,128 | 1,628,747 |
| Revenue | 89,122 | 87,992 | 168,796 | 16,142 |
| EBITDA | (114,089) | (87,799) | 65,630 | (50,797) |
| Net Income | (109,594) | (84,553) | 67,975 | (54,450) |
| Total Assets | 756,795 | 522,504 | 349,845 | 111,610 |
| Total Debt | 23,800 | 21,138 | 0 | 2,325 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Arrowhead Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
This information is available in the PitchBook Platform. To explore Arrowhead Pharmaceuticals‘s full profile, request access.
Request a free trialArrowhead Pharmaceuticals Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to tr
Biotechnology
Pasadena, CA
232
As of 2020
00.000
000000 - 000
00.000
0000000
nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor
0000 000000000
Cambridge, MA
0000
As of 0000
00.000
000000000
00.000
0000000
Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatu
000000000000000
Cambridge, MA
000
As of 0000
00000
00000000000
00000
Add Comparison
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialArrowhead Pharmaceuticals Competitors (55)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Alnylam Pharmaceuticals | Formerly VC-backed | Cambridge, MA | 0000 | 00.000 | 000000000 | 00.000 |
| 0000000 0000000000 | Formerly VC-backed | Cambridge, MA | 000 | 00000 | 00000000000 | 00000 |
| 00000000 000000000 | Formerly VC-backed | Cambridge, MA | 000 | 0000 | 000000 - 000 | 0000 |
| 0000000 0000000000 | Corporation | San Diego, CA | 00 | 00000 | 000000000 | 00000 |
| 000000 00000000000 | Formerly VC-backed | San Diego, CA | 000 | 00000 | 000000&0 |
Arrowhead Pharmaceuticals Executive Team (14)
Arrowhead Pharmaceuticals Board Members (10)
| Name | Representing | Role | Since |
|---|---|---|---|
| 00000000000 00000000 00.0 | Arrowhead Pharmaceuticals | Chief Executive Officer & Board Member | 000 0000 |
| 00000000 00000 00 | Self | Chairman & Board Member | 000 0000 |
| 00000 0000000 00.0 | Self | Board Member | 000 0000 |
| 0000000 00000 00.0 | Self | Board Member | 000 0000 |
| 000 00000000 00 | Arrowhead Pharmaceuticals | Board Member | 000 0000 |
Arrowhead Pharmaceuticals Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialArrowhead Pharmaceuticals Investments & Acquisitions (9)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 00000000 (0000 000 | 05-Mar-2015 | 000000000000000000 | 0000 | Biotechnology | 00000000000 00000000 00.0 |
| 00000 000000000000 | 11-Apr-2012 | 000000000000000000 | 000 | Drug Discovery | |
| 00000 0000000 (000 | 24-Oct-2011 | 000000000000000000 | 00.00 | Drug Delivery | 00000000000 00000000 00.0 |
| 000000 | 15-Jul-2009 | 000000000000000000 | Electrical Equipment | ||
| Masa Energy | 29-Dec-2008 | Merger/Acquisition | 00000 | Holding Companies |
Arrowhead Pharmaceuticals Exits (5)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| 000000 | 15-Jul-2009 | 000000000000000000 | Completed |
|
|
| 000000 | 17-Jun-2008 | 00000 00000 00 | 000 | Completed |
|
| 0000000 0000000000 | 16-Oct-2006 | 00000 00000 00 | 000.00 | Completed |
|
| 0000000 0000000000 | 04-Jun-2004 | 000000000000000000 | Completed |
|
|
| Unidym | Early Stage VC | 000 | Completed |